Clinical trial recruitment has become almost exclusively data-driven. We have access to vast amounts of statistics, analytics, algorithms, and performance metrics aimed at optimising outreach and enrollment.
The allure of this data is the promise of efficiency, targeted messaging, reaching the right demographics, and measuring impact with quantitative precision. Are we becoming so focused on the what (the numbers) that we’re missing the why and the who (the human experience)?
The Power and Pitfalls of a Data-Only View
Data could easily be the most powerful tool in research. It identifies trends, segments audiences, tracks reach, and A/B tests specific elements of clinical trial messaging. It provides valuable signals.
But where do algorithms fall short? Data that isn’t paired with human understanding faces the following limitations:
- The language patients use to describe their condition and treatment journey.
- Their core motivations, fears, and hopes related to trial participation.
- The practical and emotional barriers they face.
- Who they trust and where they look for information.
- What kind of support makes a real difference.
Whispers Becoming Louder
The importance of authentic communication is frequently discussed within patient communities and by advocates. Online conversations, for instance on platforms like LinkedIn or Facebook, often feature reflections on recruitment materials – highlighting when clinical trial messaging felt cold, routine or missed the mark versus when it felt genuinely understanding and human, often because patient input was clearly incorporated. This lived experience underscores the need to listen.
I recently wrote the following LinkedIn post in hopes of sparking genuine discussion with researchers and patients alike:
We have the data, but are we listening to the people? I’m finding that the clinical trial applications I am reviewing are missing a vital component: the human element when it comes to making patients aware of trials…we seem bogged down in stats and algorithms and this is dictating our messaging…it’s simply not engaging but it does fit “a way of working.”
Yes, we need CTR’s above 2%, and conversions above 10%, and 30% or more enrolment from underrepresented groups, but what are those numbers really telling us?
- Use data to inform, not dictate. Numbers are a tool to find people, not the goal.
- Create content that is data driven but ensure it’s human focused.
- Focus on retention, not just recruitment. A person who joins your clinical trial is a person who trusts you as they understand the start, middle and end of the journey.
If you want to focus on data, how about this novel approach, ASK the patients what they need, and actually listen.
Harmonising Data and Dialogue: Practical Steps
Designing good communication isn’t about pleasing stakeholders—it’s about serving participants. And the only way to do that well is to listen, learn, and improve, again and again. Listening is not reactive—it’s proactive. It means following up, circling back, and making sure every participant sees how their input made a difference. That kind of engagement pays dividends, not in clicks, but in trust.
Data Informs, Insights Guide
View data and insights as complementary. Use quantitative data to identify where to look, and qualitative insights to understand what you're seeing and how to respond.
Listen First, Message Later
Gather patient insights before creating messaging strategies and recruitment campaigns, not just using patients to test pre-determined messages.
Co-Creation is Key
Develop recruitment materials with patients, ensuring language, tone, and content resonate and address real concerns.
Qualitative Exploration
Invest in methods like patient interviews, focus groups, journey mapping, and careful social listening (beyond just sentiment scores).
Empower Internal Teams
Foster collaboration between data analysts, marketing teams, and patient engagement specialists. Train teams to appreciate and interpret both types of information.
Feedback Loops
Create mechanisms to gather feedback on recruitment materials and processes directly from potential participants.
The future of clinical research depends on more than new platforms or expanded datasets. It depends on connection. And connection doesn’t come from algorithms. It comes from listening. The best trial strategies won’t just optimise messaging—they’ll transform it. They’ll start with real questions, build in space for feedback, and focus on what people care about. They’ll be tested not just for response, but for respect.
Keith Berelowitz | Founder & CEO
Keith Berelowitz is the Founder of pRxEngage, a company redefining patient engagement and retention in clinical trials using living experience, proven methods, and AI.
